J Oosterwijk-Wakka
Overview
Explore the profile of J Oosterwijk-Wakka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuininga J, van Moerkerk H, Hanssen A, Hulsbergen C, Oosterwijk-Wakka J, Oosterwijk E, et al.
Biomaterials
. 2003 Dec;
25(9):1657-61.
PMID: 14697867
A rabbit model was used for the evaluation of a collagen-based biomatrix of small intestinal submucosa (SIS, COOK) in comparison to a biochemically reconstructed biomatrix for bladder tissue regeneration. Rabbits...
2.
Nuininga J, van Moerkerk H, Hanssen A, Hulsbergen C, Oosterwijk-Wakka J, Oosterwijk E, et al.
Eur Urol
. 2003 Jul;
44(2):266-71.
PMID: 12875948
Objective: The evaluation of collagen-based biomatrix (SIS COOK((R))) in comparison to a biochemically reconstructed biomatrix for replacement of the urethra in a rabbit model as a preclinical model. Material And...
3.
Shimazui T, Oosterwijk-Wakka J, Akaza H, Bringuier P, Ruijter E, Debruyne F, et al.
Eur Urol
. 2000 Aug;
38(3):331-8.
PMID: 10940709
Objectives: Cell-cell adhesion mediated by cadherins is tight and stable and preserves tissue integrity. However, during tissue remodeling, e.g., development, adhesion may be modified for morphogenic movement. Similarly, during carcinogenesis,...
4.
Boerman O, Kranenborg M, Oosterwijk E, Griffiths G, McBride W, Oyen W, et al.
Cancer Res
. 1999 Sep;
59(17):4400-5.
PMID: 10485489
Radiolabeled monoclonal antibodies (mAbs) can target tumors selectively. Sustained activity levels in nontarget tissues limit their application. Pretargeting approaches using bispecific mAbs (bsmAbs) or the biotinavidin interaction have been proposed...